Scientists have achieved a groundbreaking advance in heart health and longevity. Researchers have identified a special version of the BPIFB4 gene, commonly found in people who live beyond 100 years, that can reverse the biological aging of the heart by more than a decade. This discovery could reshape how we approach heart disease and aging in the future.
In laboratory studies, elderly mice treated with this centenarian gene showed significant improvements in heart function, effectively rolling back the heart’s biological age by over 10 human years. Middle-aged mice also experienced a slower decline in heart performance after receiving the gene, indicating that early intervention could preserve heart health for longer periods.
The research team went further by applying the BPIFB4 gene to heart cells taken from patients with severe heart failure. Remarkably, these aged cells began functioning more like young, healthy cells. They demonstrated stronger blood vessel growth, improved pumping ability, and reduced signs of cellular aging.
Although still in preclinical stages, this breakthrough offers a powerful glimpse into future therapies that could rejuvenate aging hearts and prevent life-threatening cardiovascular conditions. By targeting the root cause of heart aging rather than just treating symptoms, this gene therapy approach could redefine how we combat heart disease and extend healthy lifespan.
Longevity & anti-aging
#Longevity #HealthyAging #ReversingAging #LifeExtension #Geroscience
Heart health & cardiology
#HeartHealth #Cardiology #CardiacRejuvenation #HeartResearch #HeartDisease
Genetics & biotech
#GeneTherapy #GeneticBreakthrough #BPIFB4 #Biotech #MolecularMedicine
General science & discovery
#MedicalBreakthrough #FutureOfMedicine #TranslationalResearch #CuttingEdgeScience
Robert Lufkin MD
Alice Frolov
Bérénice A. Benayoun, PhD
Industry Examiner
PRIMA Longevity
Lexmilian S. R. B. de Mello
Simon Mooijaart
Rhyothemis
Eishi Noguchi
jobRxiv